Goodwin today announced that Felipe M. Heiderich has joined the firm’s Life Sciences practice as a partner in Boston.
“Felipe brings an exceptional breadth of expertise spanning venture capital, private M&A, public company transactions, and licensing arrangements – all critical areas for our practice,” said Kingsley Taft, Co-Chair of Goodwin’s Life Sciences practice. “His previous in-house experience provides him with a client-centric perspective that enhances our approach to client engagement and reinforces our commitment to providing comprehensive and sophisticated counsel.”
Felipe represents life sciences, healthcare and health technology companies in all aspect of their business, with particular expertise in mergers & acquisitions, strategic licensing and collaborations, venture capital investments, and joint ventures. Felipe also advises founders and funds throughout the company-building journey, and throughout his career has advised C-level executives and Boards of Directors on company-determining strategic initiatives. Felipe comes to Goodwin most recently from Moderna, where he led the Legal team responsible for advising and executing on all aspects of Moderna’s Business Development, Licensing and M&A efforts.
In addition to Felipe, Goodwin recently has welcomed partners Bill Christiansen Ph.D. and Carl Morales to the firm’s Life Sciences practice.
With more than 240 dedicated lawyers and patent agents across all major life sciences hubs in the US, Europe, and Asia, the Goodwin team advises life sciences companies throughout the corporate lifecycle – from startup and commercial-stage to maturity – as well as investors and banks in the life sciences ecosystem. The firm understands the unique challenges life sciences companies face in securing funding, licensing and safeguarding intellectual property, establishing partnerships, bringing new products to market, opening new revenue streams, and protecting existing product lines. The team takes a multidisciplinary approach to address client’s challenges, drawing on the firm’s deep expertise across industries including technology, healthcare, real estate, finance and private equity.